With a strong clinical-stage pipeline, Agenus harnesses a combination of proprietary antibody platforms, for example Retrocyte Exhibit™ and SECANT®, and ground breaking mobile therapy techniques, positioning by itself being a essential contributor while in the biotechnology and immunotherapy arena.These built-in technologies enable for the event